Arcadia Biosciences (RKDA) Trades at $0.25 After Triangle; 4 Analysts Are Bullish MarketAxess Holdings Inc. (MKTX) Last Week

November 15, 2017 - By wolcottdaily

Arcadia Biosciences Inc (RKDA) formed triangle with $0.26 target or 3.00% above today’s $0.25 share price. Arcadia Biosciences Inc (RKDA) has $10.67M valuation. The stock decreased 7.44% or $0.02 during the last trading session, reaching $0.25. About shares traded. Arcadia Biosciences Inc (NASDAQ:RKDA) has declined 43.32% since November 15, 2016 and is downtrending. It has underperformed by 60.02% the S&P500.

Among 7 analysts covering MarketAxess Holdings (NASDAQ:MKTX), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. MarketAxess Holdings had 20 analyst reports since September 9, 2015 according to SRatingsIntel. As per Tuesday, January 31, the company rating was upgraded by Macquarie Research. Wood maintained it with “Market Perform” rating and $103 target in Wednesday, September 9 report. The rating was maintained by Keefe Bruyette & Woods with “Buy” on Thursday, August 31. The stock has “Outperform” rating by Keefe Bruyette & Woods on Thursday, October 22. Raymond James upgraded the shares of MKTX in report on Monday, October 26 to “Outperform” rating. The firm earned “Neutral” rating on Wednesday, January 25 by Credit Suisse. The stock of MarketAxess Holdings Inc. (NASDAQ:MKTX) earned “Buy” rating by Keefe Bruyette & Woods on Tuesday, October 3. Wood upgraded the shares of MKTX in report on Thursday, October 22 to “Outperform” rating. The firm earned “Buy” rating on Wednesday, July 5 by Keefe Bruyette & Woods. William Blair initiated MarketAxess Holdings Inc. (NASDAQ:MKTX) on Monday, June 20 with “Market Perform” rating. See MarketAxess Holdings Inc. (NASDAQ:MKTX) latest ratings:

10/10/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $215.0 Maintain
03/10/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $220.0 Maintain
31/08/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $220.0 Maintain
27/07/2017 Broker: Raymond James Rating: Outperform Old Target: $216 New Target: $219 Maintain
05/07/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $205.0000 Maintain
01/06/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $205.0000 Maintain

Investors sentiment increased to 1.12 in Q2 2017. Its up 0.01, from 1.11 in 2017Q1. It increased, as 22 investors sold MarketAxess Holdings Inc. shares while 108 reduced holdings. 42 funds opened positions while 104 raised stakes. 33.67 million shares or 1.71% more from 33.10 million shares in 2017Q1 were reported. Quantitative Investment Management Ltd Liability has invested 0.08% of its portfolio in MarketAxess Holdings Inc. (NASDAQ:MKTX). Kayne Anderson Rudnick Investment Management Lc invested in 1.69% or 840,526 shares. Great West Life Assurance Can holds 29,789 shares. Ashford Cap Management reported 78,181 shares. Norris Perne French Llp Mi holds 22,909 shares or 0.77% of its portfolio. Royal Bank Of Canada invested in 491,110 shares. Credit Suisse Ag stated it has 38,016 shares or 0.01% of all its holdings. Oakbrook Investments Ltd Liability owns 2,556 shares for 0.03% of their portfolio. 233,552 are held by Waddell & Reed Fin Inc. Canandaigua Natl Bank & Co accumulated 2,000 shares or 0.08% of the stock. Next Century Growth Invsts Ltd Limited Liability Company owns 127,025 shares for 2.45% of their portfolio. Principal Fin Grp Inc Inc owns 161,102 shares for 0.03% of their portfolio. Sg Americas Secs Ltd Company accumulated 7,440 shares or 0.01% of the stock. Ing Groep Nv reported 4,572 shares or 0.02% of all its holdings. 18,361 are owned by Mason Street Advsrs Ltd.

The stock decreased 0.33% or $0.58 during the last trading session, reaching $173.94. About shares traded. MarketAxess Holdings Inc. (NASDAQ:MKTX) has risen 40.00% since November 15, 2016 and is uptrending. It has outperformed by 23.30% the S&P500.

Since May 17, 2017, it had 0 insider buys, and 2 insider sales for $2.99 million activity. The insider Themelis Nicholas sold 5,596 shares worth $1.12M. 230 MarketAxess Holdings Inc. (NASDAQ:MKTX) shares with value of $42,481 were sold by Casper Stephen P. The insider McPherson Kevin M sold 9,286 shares worth $1.87 million.

MarketAxess Holdings Inc. operates an electronic trading platform that enables fixed-income market participants to trade corporate bonds and other types of fixed-income instruments using its trading technology. The company has market cap of $6.53 billion. Institutional investor and broker-dealer firms are users of trading platform, accessing global liquidity in the United States corporate bonds, emerging markets and high-yield bonds, European bonds, the United States agency bonds, municipal bonds, credit default swaps and other fixed-income securities. It has a 44.72 P/E ratio. Through Open Trading protocols, it executes trades in certain bonds between and among institutional investor and broker-dealer clients in a trading environment on a matched principal basis.

Among 2 analysts covering Arcadia Biosciences (NASDAQ:RKDA), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Arcadia Biosciences had 2 analyst reports since May 12, 2017 according to SRatingsIntel. As per Friday, July 21, the company rating was maintained by Piper Jaffray. The rating was downgraded by PiperJaffray to “Neutral” on Friday, May 12.

Analysts await Arcadia Biosciences Inc (NASDAQ:RKDA) to report earnings on March, 14. They expect $-0.08 earnings per share, up 38.46% or $0.05 from last year’s $-0.13 per share. After $-0.11 actual earnings per share reported by Arcadia Biosciences Inc for the previous quarter, Wall Street now forecasts -27.27% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 wolcottdaily




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: